0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover2289.70%IV-56.74%PremiumNov 29, 2024Expiry Date3.62Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.6826Delta0.0954Gamma1.52Leverage Ratio-2.8228Theta-0.0001Rho-1.04Eff Leverage0.0006Vega
Recursion Pharmaceuticals Stock Discussion
especially after acquiring Exscientia the competition has turned into synnergy
recent investment from Cathie Wood
ARK investment
This $NVIDIA (NVDA.US)$ portfolio company recently acquired Exacientia UK based company.
Buy for the target of 9
only Pharma company in $NVIDIA (NVDA.US)$ Portfolio using AI for drug discovery
No comment yet